UK: New study vindicates delaying 2nd virus vaccine dose
LONDON (AP) — Britain’s health chief said Wednesday that a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks supports the government’s strategy of delaying the second shot so more people can quickly be protected by the first dose.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
